View in EDS

P-586 Phase II study of docetaxel and celecoxib as first or second linetherapy in patients with advanced NSCLC

Saved in:
Bibliographic Details
Title: P-586 Phase II study of docetaxel and celecoxib as first or second linetherapy in patients with advanced NSCLC
Authors: Underhill, C., Hui, R., Links, M., Hawson, G., Chern, B., Yip, D., Blackwell, T., Crombie, C., Boyer, M.
Source: Lung Cancer (01695002). Jul2005 Supplement 2, Vol. 49, pS272-S272. 1p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first